662 related articles for article (PubMed ID: 33345256)
1. Aβ Plaques.
Walker LC
Free Neuropathol; 2020; 1():. PubMed ID: 33345256
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Regression stage senile plaques in the natural course of Alzheimer's disease.
Oide T; Kinoshita T; Arima K
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
6. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
7. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
8. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
10. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
11. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
[TBL] [Abstract][Full Text] [Related]
12. Prion-like mechanisms in Alzheimer disease.
Walker LC
Handb Clin Neurol; 2018; 153():303-319. PubMed ID: 29887142
[TBL] [Abstract][Full Text] [Related]
13. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Sortilin Proteopathy Relative to β-Amyloid and Tau in Aged and Alzheimer's Disease Human Brains.
Tu T; Jiang J; Zhang QL; Wan L; Li YN; Pan A; Manavis J; Yan XX
Front Aging Neurosci; 2020; 12():93. PubMed ID: 32477092
[TBL] [Abstract][Full Text] [Related]
15. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.
Standridge JB
Curr Alzheimer Res; 2006 Apr; 3(2):95-108. PubMed ID: 16611010
[TBL] [Abstract][Full Text] [Related]
16. The Exceptional Vulnerability of Humans to Alzheimer's Disease.
Walker LC; Jucker M
Trends Mol Med; 2017 Jun; 23(6):534-545. PubMed ID: 28483344
[TBL] [Abstract][Full Text] [Related]
17. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
18. The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ.
Kalimo H; Lalowski M; Bogdanovic N; Philipson O; Bird TD; Nochlin D; Schellenberg GD; Brundin R; Olofsson T; Soliymani R; Baumann M; Wirths O; Bayer TA; Nilsson LN; Basun H; Lannfelt L; Ingelsson M
Acta Neuropathol Commun; 2013 Sep; 1():60. PubMed ID: 24252272
[TBL] [Abstract][Full Text] [Related]
19. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
20. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
